Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Genomic prognostics for prostate cancer salvage radiotherapy

Bridget Koontz, MD, Duke University Medical Center, Durham, NC, discusses the validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.